<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30037331</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1423-0127</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Journal of biomedical science</Title><ISOAbbreviation>J Biomed Sci</ISOAbbreviation></Journal><ArticleTitle>Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate.</ArticleTitle><Pagination><StartPage>58</StartPage><MedlinePgn>58</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">58</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12929-018-0462-0</ELocationID><Abstract><AbstractText>Dengue virus (DENV) infection is the most common mosquito-transmitted viral infection. DENV infection can cause mild dengue fever or severe dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Hemorrhage and vascular leakage are two characteristic symptoms of DHF/DSS. However, due to the limited understanding of dengue pathogenesis, no satisfactory therapies to treat nor vaccine to prevent dengue infection are available, and the mortality of DHF/DSS is still high. DENV nonstructural protein 1 (NS1), which can be secreted in patients' sera, has been used as an early diagnostic marker for dengue infection for many years. However, the roles of NS1 in dengue-induced vascular leakage were described only recently. In this article, the pathogenic roles of DENV NS1 in hemorrhage and vascular leakage are reviewed, and the possibility of using NS1 as a therapeutic target and vaccine candidate is discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hong-Ru</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>The Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Yen-Chung</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>The Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Trai-Ming</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0003-3172-7432</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. today@mail.ncku.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>102-2320-B-006-025-MY3</GrantID><Agency>Ministry of Science and Technology, Taiwan</Agency><Country/></Grant><Grant><GrantID>105-2321-B-006-023</GrantID><Agency>Ministry of Science and Technology, Taiwan</Agency><Country/></Grant><Grant><GrantID>106-2321-B-006 -011</GrantID><Agency>Ministry of Science and Technology, Taiwan</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Biomed Sci</MedlineTA><NlmUniqueID>9421567</NlmUniqueID><ISSNLinking>1021-7770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C082515">NS1 protein, dengue-1 virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019595" MajorTopicYN="N">Severe Dengue</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coagulopathy</Keyword><Keyword MajorTopicYN="N">Dengue virus (DENV)</Keyword><Keyword MajorTopicYN="N">Hemorrhage</Keyword><Keyword MajorTopicYN="N">Nonstructural protein 1 (NS1)</Keyword><Keyword MajorTopicYN="N">Vaccine</Keyword><Keyword MajorTopicYN="N">Vascular leakage</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30037331</ArticleId><ArticleId IdType="pmc">PMC6057007</ArticleId><ArticleId IdType="doi">10.1186/s12929-018-0462-0</ArticleId><ArticleId IdType="pii">10.1186/s12929-018-0462-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Dengue haemorrhagic fever . diagnosis, treatment, prevention and control. 2. Geneva: World Health Organization; 1997.</Citation></Reference><Reference><Citation>Kalayanarooj S. Standardized Clinical Management: Evidence of Reduction of Dengue Haemorrhagic Fever Case-Fatality Rate in Thailand. Dengue Bulletin. 1999;23:10&#x2013;17.</Citation></Reference><Reference><Citation>Bravo L, Roque VG, Brett J, Dizon R, L'Azou M. Epidemiology of dengue disease in the Philippines (2000-2011): a systematic literature review. PLoS Negl Trop Dis. 2014;8(11):e3027. doi: 10.1371/journal.pntd.0003027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003027</ArticleId><ArticleId IdType="pmc">PMC4222740</ArticleId><ArticleId IdType="pubmed">25375119</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC. Immunopathogenesis of dengue virus infection. J Biomed Sci. 2001;8(5):377&#x2013;388. doi: 10.1007/BF02255946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02255946</ArticleId><ArticleId IdType="pubmed">11549879</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg. 1989;40(41):444&#x2013;451. doi: 10.4269/ajtmh.1989.40.444.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1989.40.444</ArticleId><ArticleId IdType="pubmed">2712199</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Venkateshan CN, Gentry MK, Larsen LK. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol. 1984;132(31):1529&#x2013;1532.</Citation><ArticleIdList><ArticleId IdType="pubmed">6607288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988;38(21):411&#x2013;419. doi: 10.4269/ajtmh.1988.38.411.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1988.38.411</ArticleId><ArticleId IdType="pubmed">3354774</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell. 2002;108(5):717&#x2013;725. doi: 10.1016/S0092-8674(02)00660-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00660-8</ArticleId><ArticleId IdType="pmc">PMC4152842</ArticleId><ArticleId IdType="pubmed">11893341</ArticleId></ArticleIdList></Reference><Reference><Citation>Byk LA, Gamarnik AV. Properties and Functions of the Dengue Virus Capsid Protein. Annu Rev Virol. 2016;3(1):263&#x2013;281. doi: 10.1146/annurev-virology-110615-042334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-110615-042334</ArticleId><ArticleId IdType="pmc">PMC5417333</ArticleId><ArticleId IdType="pubmed">27501261</ArticleId></ArticleIdList></Reference><Reference><Citation>Christian EA, Kahle KM, Mattia K, Puffer BA, Pfaff JM, Miller A, Paes C, Davidson E, Doranz BJ. Atomic-level functional model of dengue virus Envelope protein infectivity. Proc Natl Acad Sci USA. 2013;110(46):18662&#x2013;18667. doi: 10.1073/pnas.1310962110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1310962110</ArticleId><ArticleId IdType="pmc">PMC3831943</ArticleId><ArticleId IdType="pubmed">24158478</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller DA, Young PR. The flavivirus NS1 protein: Molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 2013;98(2):192&#x2013;208. doi: 10.1016/j.antiviral.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.03.008</ArticleId><ArticleId IdType="pubmed">23523765</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn S, Li T, McCune BT, Edeling MA, Fremont DH, Cristea IM, Diamond MS. Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus. J Virol. 2012;86(13):7360&#x2013;7371. doi: 10.1128/JVI.00157-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00157-12</ArticleId><ArticleId IdType="pmc">PMC3416313</ArticleId><ArticleId IdType="pubmed">22553322</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenbach BD, Rice CM. Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J Virol. 1999;73(6):4611&#x2013;4621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112502</ArticleId><ArticleId IdType="pubmed">10233920</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs MG, Robinson PJ, Bletchly C, Mackenzie JM, Young PR. Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J. 2000;14(11):1603&#x2013;1610. doi: 10.1096/fj.99-0829com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.99-0829com</ArticleId><ArticleId IdType="pubmed">10928995</ArticleId></ArticleIdList></Reference><Reference><Citation>Noisakran S, Dechtawewat T, Avirutnan P, Kinoshita T, Siripanyaphinyo U, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N. Association of dengue virus NS1 protein with lipid rafts. J Gen Virol. 2008;89(Pt 10):2492&#x2013;2500. doi: 10.1099/vir.0.83620-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83620-0</ArticleId><ArticleId IdType="pubmed">18796718</ArticleId></ArticleIdList></Reference><Reference><Citation>Edeling MA, Diamond MS, Fremont DH. Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc Natl Acad Sci U S A. 2014;111(11):4285&#x2013;4290. doi: 10.1073/pnas.1322036111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1322036111</ArticleId><ArticleId IdType="pmc">PMC3964132</ArticleId><ArticleId IdType="pubmed">24594604</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutsche I, Coulibaly F, Voss JE, Salmon J, d'Alayer J, Ermonval M, Larquet E, Charneau P, Krey T, Megret F, et al. Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. Proc Natl Acad Sci U S A. 2011;108(19):8003&#x2013;8008. doi: 10.1073/pnas.1017338108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017338108</ArticleId><ArticleId IdType="pmc">PMC3093454</ArticleId><ArticleId IdType="pubmed">21518917</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, Zhang L, Punyadee N, Manuyakorn A, Puttikhunt C, Kasinrerk W, Malasit P, Atkinson JP, Diamond MS. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog. 2007;3(11):e183. doi: 10.1371/journal.ppat.0030183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0030183</ArticleId><ArticleId IdType="pmc">PMC2092380</ArticleId><ArticleId IdType="pubmed">18052531</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YC, Wang SY, Lin YS, Chen HR, Yeh TM. Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection. J Biomed Sci. 2013;20:42. doi: 10.1186/1423-0127-20-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-42</ArticleId><ArticleId IdType="pmc">PMC3704815</ArticleId><ArticleId IdType="pubmed">23806052</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol. 2002;40(2):376&#x2013;381. doi: 10.1128/JCM.40.02.376-381.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.02.376-381.2002</ArticleId><ArticleId IdType="pmc">PMC153354</ArticleId><ArticleId IdType="pubmed">11825945</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002;186(8):1165&#x2013;1168. doi: 10.1086/343813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/343813</ArticleId><ArticleId IdType="pubmed">12355369</ArticleId></ArticleIdList></Reference><Reference><Citation>Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol. 2000;38(3):1053&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86336</ArticleId><ArticleId IdType="pubmed">10698995</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, Fuchs A, Hauhart RE, Somnuke P, Youn S, Diamond MS, Atkinson JP. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med. 2010;207(4):793&#x2013;806. doi: 10.1084/jem.20092545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20092545</ArticleId><ArticleId IdType="pmc">PMC2856034</ArticleId><ArticleId IdType="pubmed">20308361</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, Hauhart RE, Somnuke P, Blom AM, Diamond MS, Atkinson JP. Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J Immunol. 2011;187(1):424&#x2013;433. doi: 10.4049/jimmunol.1100750.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100750</ArticleId><ArticleId IdType="pmc">PMC3119735</ArticleId><ArticleId IdType="pubmed">21642539</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TJ, Brandt WE, Swanson JL, McCown JM, Buescher EL. Physical and biological properties of dengue-2 virus and associated antigens. J Virol. 1970;5(41):524&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC376035</ArticleId><ArticleId IdType="pubmed">4195055</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao H, Xu J, Huang J. FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells. J Med Virol. 2010;82(8):1392&#x2013;1399. doi: 10.1002/jmv.21815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21815</ArticleId><ArticleId IdType="pubmed">20572077</ArticleId></ArticleIdList></Reference><Reference><Citation>Long X, Li Y, Qi Y, Xu J, Wang Z, Zhang X, Zhang D, Zhang L, Huang J. XAF1 contributes to dengue virus-induced apoptosis in vascular endothelial cells. FASEB J. 2013;27(3):1062&#x2013;1073. doi: 10.1096/fj.12-213967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.12-213967</ArticleId><ArticleId IdType="pubmed">23207547</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol. 2007;81(11):5518&#x2013;5526. doi: 10.1128/JVI.02575-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02575-06</ArticleId><ArticleId IdType="pmc">PMC1900309</ArticleId><ArticleId IdType="pubmed">17360740</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HJ, Luo YH, Wan SW, Lin CF, Wang ST, Hung NT, Liu CC, Ho TS, Liu HS, Yeh TM, et al. Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients. Am J Trop Med Hyg. 2015;92(5):989&#x2013;995. doi: 10.4269/ajtmh.14-0162.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.14-0162</ArticleId><ArticleId IdType="pmc">PMC4426591</ArticleId><ArticleId IdType="pubmed">25758647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, Liu CC, Chiu SC, Lin YS. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol. 2002;169(2):657&#x2013;664. doi: 10.4049/jimmunol.169.2.657.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.2.657</ArticleId><ArticleId IdType="pubmed">12097367</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CL, Lin CF, Wan SW, Wei LS, Chen MC, Yeh TM, Liu HS, Anderson R, Lin YS. Anti-dengue virus nonstructural protein 1 antibodies cause NO-mediated endothelial cell apoptosis via ceramide-regulated glycogen synthase kinase-3beta and NF-kappaB activation. J Immunol. 2013;191(4):1744&#x2013;1752. doi: 10.4049/jimmunol.1201976.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201976</ArticleId><ArticleId IdType="pubmed">23851680</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Chiu SC, Hsiao YL, Wan SW, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, Liu CC, et al. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol. 2005;174(1):395&#x2013;403. doi: 10.4049/jimmunol.174.1.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.1.395</ArticleId><ArticleId IdType="pubmed">15611263</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HJ, Lin CF, Lei HY, Liu HS, Yeh TM, Luo YH, Lin YS. Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies. Exp Biol Med (Maywood) 2009;234(1):63&#x2013;73. doi: 10.3181/0805-RM-147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0805-RM-147</ArticleId><ArticleId IdType="pubmed">18997103</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, Jairungsri A, Kanlaya R, Tangthawornchaikul N, Puttikhunt C, et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis. 2006;193(8):1078&#x2013;1088. doi: 10.1086/500949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/500949</ArticleId><ArticleId IdType="pubmed">16544248</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SJ. NS1: A corner piece in the dengue pathogenesis puzzle? Sci Transl Med. 2015;7(304):304fs337. doi: 10.1126/scitranslmed.aad1255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aad1255</ArticleId><ArticleId IdType="pubmed">26355028</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Pathogenesis of Dengue: Dawn of a New Era. F1000Res. 2015;4:1353&#x2013;60.&#xa0;</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4754012</ArticleId><ArticleId IdType="pubmed">26918141</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatty PR, Puerta-Guardo H, Killingbeck SS, Glasner DR, Hopkins K, Harris E. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med. 2015;7(304):304ra141. doi: 10.1126/scitranslmed.aaa3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa3787</ArticleId><ArticleId IdType="pubmed">26355030</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Ng MM, Chu JJ. Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection. PLoS Pathog. 2015;11(7):e1005053. doi: 10.1371/journal.ppat.1005053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005053</ArticleId><ArticleId IdType="pmc">PMC4520596</ArticleId><ArticleId IdType="pubmed">26226614</ArticleId></ArticleIdList></Reference><Reference><Citation>Modhiran N, Watterson D, Muller DA, Panetta AK, Sester DP, Liu L, Hume DA, Stacey KJ, Young PR. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med. 2015;7(304):304ra142. doi: 10.1126/scitranslmed.aaa3863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa3863</ArticleId><ArticleId IdType="pubmed">26355031</ArticleId></ArticleIdList></Reference><Reference><Citation>Modhiran N, Watterson D, Blumenthal A, Baxter AG, Young PR, Stacey KJ. Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6. Immunol Cell Biol. 2017;95(5):491&#x2013;495. doi: 10.1038/icb.2017.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2017.5</ArticleId><ArticleId IdType="pubmed">28220810</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasner DR, Ratnasiri K, Puerta-Guardo H, Espinosa DA, Beatty PR, Harris E. Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components. PLoS Pathog. 2017;13(11):e1006673. doi: 10.1371/journal.ppat.1006673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006673</ArticleId><ArticleId IdType="pmc">PMC5679539</ArticleId><ArticleId IdType="pubmed">29121099</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HR, Chuang YC, Lin YS, Liu HS, Liu CC, Perng GC, Yeh TM. Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy. PLoS Negl Trop Dis. 2016;10(7):e0004828. doi: 10.1371/journal.pntd.0004828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004828</ArticleId><ArticleId IdType="pmc">PMC4943727</ArticleId><ArticleId IdType="pubmed">27409803</ArticleId></ArticleIdList></Reference><Reference><Citation>Assuncao-Miranda I, Amaral FA, Bozza FA, Fagundes CT, Sousa LP, Souza DG, Pacheco P, Barbosa-Lima G, Gomes RN, Bozza PT, et al. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J. 2010;24(1):218&#x2013;228. doi: 10.1096/fj.09-139469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-139469</ArticleId><ArticleId IdType="pubmed">19776337</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YC, Lei HY, Liu HS, Lin YS, Fu TF, Yeh TM. Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability. Cytokine. 2011;54(2):222&#x2013;231. doi: 10.1016/j.cyto.2011.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2011.01.013</ArticleId><ArticleId IdType="pubmed">21320786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira RA, de Oliveira SA, Gandini M, Ferreira Lda C, Correa G, Abiraude FM, Reid MM, Cruz OG, Kubelka CF. Circulating cytokines and chemokines associated with plasma leakage and hepatic dysfunction in Brazilian children with dengue fever. Acta Trop. 2015;149:138&#x2013;147. doi: 10.1016/j.actatropica.2015.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actatropica.2015.04.023</ArticleId><ArticleId IdType="pubmed">25944351</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong YK, Tan HY, Jen SH, Shankar EM, Natkunam SK, Sathar J, Manikam R, Sekaran SD. Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease. J Transl Med. 2017;15(1):121. doi: 10.1186/s12967-017-1226-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1226-4</ArticleId><ArticleId IdType="pmc">PMC5452397</ArticleId><ArticleId IdType="pubmed">28569153</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg. 2006;74(1):142&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">16407359</ArticleId></ArticleIdList></Reference><Reference><Citation>Puerta-Guardo H, Glasner DR, Harris E. Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability. PLoS Pathog. 2016;12(7):e1005738. doi: 10.1371/journal.ppat.1005738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005738</ArticleId><ArticleId IdType="pmc">PMC4944995</ArticleId><ArticleId IdType="pubmed">27416066</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007;454(3):345&#x2013;359. doi: 10.1007/s00424-007-0212-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-007-0212-8</ArticleId><ArticleId IdType="pmc">PMC1915585</ArticleId><ArticleId IdType="pubmed">17256154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipowsky HH. The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Ann Biomed Eng. 2012;40(4):840&#x2013;848. doi: 10.1007/s10439-011-0427-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10439-011-0427-x</ArticleId><ArticleId IdType="pmc">PMC3306510</ArticleId><ArticleId IdType="pubmed">21984514</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L, Zemans RL, Bowman JC, Koyanagi DE, Yunt ZX, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med. 2012;18(8):1217&#x2013;1223. doi: 10.1038/nm.2843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2843</ArticleId><ArticleId IdType="pmc">PMC3723751</ArticleId><ArticleId IdType="pubmed">22820644</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai K, Wang W. Spatio-temporal development of the endothelial glycocalyx layer and its mechanical property in vitro. J R Soc Interface. 2012;9(74):2290&#x2013;2298. doi: 10.1098/rsif.2011.0901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2011.0901</ArticleId><ArticleId IdType="pmc">PMC3405740</ArticleId><ArticleId IdType="pubmed">22417911</ArticleId></ArticleIdList></Reference><Reference><Citation>Dull RO, Cluff M, Kingston J, Hill D, Chen H, Hoehne S, Malleske DT, Kaur R. Lung heparan sulfates modulate K(fc) during increased vascular pressure: evidence for glycocalyx-mediated mechanotransduction. Am J Physiol Lung Cell Mol Physiol. 2012;302(9):L816&#x2013;L828. doi: 10.1152/ajplung.00080.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00080.2011</ArticleId><ArticleId IdType="pmc">PMC3362156</ArticleId><ArticleId IdType="pubmed">22160307</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker BF, Chappell D, Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol. 2010;105(6):687&#x2013;701. doi: 10.1007/s00395-010-0118-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-010-0118-z</ArticleId><ArticleId IdType="pubmed">20859744</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell D, Jacob M, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF. Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx. Biol Chem. 2008;389(1):79&#x2013;82. doi: 10.1515/BC.2008.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/BC.2008.005</ArticleId><ArticleId IdType="pubmed">18095872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Macleod V, Miao HQ, Theus A, Zhan F, Shaughnessy JD, Jr, Sawyer J, Li JP, Zcharia E, Vlodavsky I, et al. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J Biol Chem. 2007;282(18):13326&#x2013;13333. doi: 10.1074/jbc.M611259200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M611259200</ArticleId><ArticleId IdType="pubmed">17347152</ArticleId></ArticleIdList></Reference><Reference><Citation>Purushothaman A, Uyama T, Kobayashi F, Yamada S, Sugahara K, Rapraeger AC, Sanderson RD. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood. 2010;115(12):2449&#x2013;2457. doi: 10.1182/blood-2009-07-234757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-07-234757</ArticleId><ArticleId IdType="pmc">PMC2845901</ArticleId><ArticleId IdType="pubmed">20097882</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulivor AW, Lipowsky HH. Inhibition of glycan shedding and leukocyte-endothelial adhesion in postcapillary venules by suppression of matrixmetalloprotease activity with doxycycline. Microcirculation (New York, NY : 1994) 2009;16(8):657&#x2013;666. doi: 10.3109/10739680903133714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10739680903133714</ArticleId><ArticleId IdType="pubmed">19905966</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipowsky HH. Protease Activity and the Role of the Endothelial Glycocalyx in Inflammation. Drug Discov Today Dis Models. 2011;8(1):57&#x2013;62. doi: 10.1016/j.ddmod.2011.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ddmod.2011.05.004</ArticleId><ArticleId IdType="pmc">PMC3206297</ArticleId><ArticleId IdType="pubmed">22059089</ArticleId></ArticleIdList></Reference><Reference><Citation>Voraphani N, Khongphatthanayothin A, Srikaew K, Tontulawat P, Poovorawan Y. Matrix metalloproteinase-9 (mmp-9) in children with dengue virus infection. Jpn J Infect Dis. 2010;63(5):346&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20859002</ArticleId></ArticleIdList></Reference><Reference><Citation>Her Z, Kam YW, Gan VC, Lee B, Thein TL, Tan JJ, Lee LK, Fink K, Lye DC, Renia L, et al. Severity of Plasma Leakage Is Associated With High Levels of Interferon gamma-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection. J Infect Dis. 2017;215(1):42&#x2013;51. doi: 10.1093/infdis/jiw494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw494</ArticleId><ArticleId IdType="pubmed">28077582</ArticleId></ArticleIdList></Reference><Reference><Citation>Luplertlop N, Misse D. MMP cellular responses to dengue virus infection-induced vascular leakage. Jpn J Infect Dis. 2008;61(4):298&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">18653973</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwarto S, Sasmono RT, Sinto R, Ibrahim E, Suryamin M. Association of Endothelial Glycocalyx and Tight and Adherens Junctions With Severity of Plasma Leakage in Dengue Infection. J Infect Dis. 2017;215(6):992&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407050</ArticleId><ArticleId IdType="pubmed">28453844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HR, Chao CH, Liu CC, Ho TS, Tsai HP, Perng GC, Lin YS, Wang JR, Yeh TM. Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability. PLoS Pathog. 2018;14(4):e1007033. doi: 10.1371/journal.ppat.1007033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007033</ArticleId><ArticleId IdType="pmc">PMC6044858</ArticleId><ArticleId IdType="pubmed">29702687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SW, Chuang YC, Lin YS, Lei HY, Liu HS, Yeh TM. Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation. J Infect. 2012;64(3):325&#x2013;334. doi: 10.1016/j.jinf.2011.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2011.11.023</ArticleId><ArticleId IdType="pubmed">22138554</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, Du X, Li Z. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol. 2009;182(12):7997&#x2013;8004. doi: 10.4049/jimmunol.0802884.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0802884</ArticleId><ArticleId IdType="pmc">PMC2787095</ArticleId><ArticleId IdType="pubmed">19494325</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181(1):2&#x2013;9. doi: 10.1086/315215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315215</ArticleId><ArticleId IdType="pubmed">10608744</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, Lin SC, Ho ST, Huang JH, King CC. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology. 2003;305(2):330&#x2013;338. doi: 10.1006/viro.2002.1704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2002.1704</ArticleId><ArticleId IdType="pubmed">12573578</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmeyer R. Virus attachment and entry offer numerous targets for antiviral therapy. Curr Pharm Des. 2004;10(30):3701&#x2013;3712. doi: 10.2174/1381612043382729.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612043382729</ArticleId><ArticleId IdType="pubmed">15579065</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, Wills B, Tran HT, Simmons CP. A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis. 2010;4(8):e785. doi: 10.1371/journal.pntd.0000785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000785</ArticleId><ArticleId IdType="pmc">PMC2919376</ArticleId><ArticleId IdType="pubmed">20706626</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Guardia C, Lleonart R. Progress in the identification of dengue virus entry/fusion inhibitors. Biomed Res Int. 2014;2014:825039. doi: 10.1155/2014/825039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/825039</ArticleId><ArticleId IdType="pmc">PMC4135166</ArticleId><ArticleId IdType="pubmed">25157370</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NM, Tran CN, Phung LK, Duong KT, Huynh Hle A, Farrar J, Nguyen QT, Tran HT, Nguyen CV, Merson L, et al. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis. 2013;207(9):1442&#x2013;1450. doi: 10.1093/infdis/jis470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis470</ArticleId><ArticleId IdType="pmc">PMC3610419</ArticleId><ArticleId IdType="pubmed">22807519</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan HA, Han HC, Ramasamy TS, Othman S, Rahman NA, Yusof R. Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1. BMC Infect Dis. 2012;12:314. doi: 10.1186/1471-2334-12-314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-314</ArticleId><ArticleId IdType="pmc">PMC3575220</ArticleId><ArticleId IdType="pubmed">23171075</ArticleId></ArticleIdList></Reference><Reference><Citation>van Cleef KWR, Overheul GJ, Thomassen MC, Kaptein SJF, Davidson AD, Jacobs M, Neyts J, van Kuppeveld FJM, van Rij RP. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication. Antivir Res. 2013;99(2):165&#x2013;171. doi: 10.1016/j.antiviral.2013.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.05.011</ArticleId><ArticleId IdType="pubmed">23735301</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang QY, Kondreddi RR, Xie XP, Rao R, Nilar S, Xu HY, Qing M, Chang D, Dong HP, Yokokawa F, et al. A Translation Inhibitor That Suppresses Dengue Virus In Vitro and In Vivo. Antimicrob Agents Ch. 2011;55(9):4072&#x2013;4080. doi: 10.1128/AAC.00620-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00620-11</ArticleId><ArticleId IdType="pmc">PMC3165312</ArticleId><ArticleId IdType="pubmed">21730119</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo E, Pezzullo M, De Burghgraeve T, Kaptein S, Pastorino B, Dallmeier K, de Lamballerie X, Neyts J, Hanson AM, Frick DN, et al. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemoth. 2012;67(8):1884&#x2013;1894. doi: 10.1093/jac/dks147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dks147</ArticleId><ArticleId IdType="pmc">PMC3888155</ArticleId><ArticleId IdType="pubmed">22535622</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathore APS, Paradkar PN, Watanabe S, Tan KH, Sung C, Connolly JE, Low J, Ooi EE, Vasudevan SG. Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model. Antivir Res. 2011;92(3):453&#x2013;460. doi: 10.1016/j.antiviral.2011.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.10.002</ArticleId><ArticleId IdType="pubmed">22020302</ArticleId></ArticleIdList></Reference><Reference><Citation>Simanjuntak Y, Liang JJ, Lee YL, Lin YL. Repurposing of prochlorperazine for use against dengue virus infection. J Infect Dis. 2015;211(3):394&#x2013;404. doi: 10.1093/infdis/jiu377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu377</ArticleId><ArticleId IdType="pubmed">25028694</ArticleId></ArticleIdList></Reference><Reference><Citation>Leela SL, Srisawat C, Sreekanth GP, Noisakran S, Yenchitsomanus PT, Limjindaporn T. Drug repurposing of minocycline against dengue virus infection. Biochem Bioph Res Co. 2016;478(1):410&#x2013;416. doi: 10.1016/j.bbrc.2016.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.07.029</ArticleId><ArticleId IdType="pubmed">27396621</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan MN, Garcia-Blanco MA. Targeting host factors to treat West Nile and dengue viral infections. Viruses. 2014;6(2):683&#x2013;708. doi: 10.3390/v6020683.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6020683</ArticleId><ArticleId IdType="pmc">PMC3939478</ArticleId><ArticleId IdType="pubmed">24517970</ArticleId></ArticleIdList></Reference><Reference><Citation>de Chassey B, Meyniel-Schicklin L, Vonderscher J, Andre P, Lotteau V. Virus-host interactomics: new insights and opportunities for antiviral drug discovery. Genome Med. 2014;6(11):115. doi: 10.1186/s13073-014-0115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-014-0115-1</ArticleId><ArticleId IdType="pmc">PMC4295275</ArticleId><ArticleId IdType="pubmed">25593595</ArticleId></ArticleIdList></Reference><Reference><Citation>Savidis G, McDougall WM, Meraner P, Perreira JM, Portmann JM, Trincucci G, John SP, Aker AM, Renzette N, Robbins DR, et al. Identification of zika virus and dengue virus dependency factors using functional genomics. Cell Rep. 2016;16(1):232&#x2013;246. doi: 10.1016/j.celrep.2016.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.06.028</ArticleId><ArticleId IdType="pubmed">27342126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhang P. Recent advances in the identification of the host factors involved in dengue virus replication. Virol Sin. 2017;32(1):23&#x2013;31. doi: 10.1007/s12250-016-3902-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-016-3902-6</ArticleId><ArticleId IdType="pmc">PMC6598876</ArticleId><ArticleId IdType="pubmed">28124222</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu JS, Wu YH, Tseng CK, Lin CK, Hsu YC, Chen YH, Lee JC. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway. Sci Rep. 2017;7:45171. doi: 10.1038/srep45171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep45171</ArticleId><ArticleId IdType="pmc">PMC5364541</ArticleId><ArticleId IdType="pubmed">28338050</ArticleId></ArticleIdList></Reference><Reference><Citation>Zainal N, Chang CP, Cheng YL, Wu YW, Anderson R, Wan SW, Chen CL, Ho TS, AbuBakar S, Lin YS. Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection. Sci Rep. 2017;7:42998. doi: 10.1038/srep42998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42998</ArticleId><ArticleId IdType="pmc">PMC5316936</ArticleId><ArticleId IdType="pubmed">28216632</ArticleId></ArticleIdList></Reference><Reference><Citation>Datan E, Roy SG, Germain G, Zali N, McLean JE, Golshan G, Harbajan S, Lockshin RA, Zakeri Z. Dengue-induced autophagy, virus replication and protection from cell death require ER stress (PERK) pathway activation. Cell Death Dis. 2016;7:e2127. doi: 10.1038/cddis.2015.409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.409</ArticleId><ArticleId IdType="pmc">PMC4823927</ArticleId><ArticleId IdType="pubmed">26938301</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontaine KA, Sanchez EL, Camarda R, Lagunoff M. Dengue virus induces and requires glycolysis for optimal replication. J Virol. 2015;89(4):2358&#x2013;2366. doi: 10.1128/JVI.02309-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02309-14</ArticleId><ArticleId IdType="pmc">PMC4338897</ArticleId><ArticleId IdType="pubmed">25505078</ArticleId></ArticleIdList></Reference><Reference><Citation>Low JG, Ooi EE, Vasudevan SG. Current status of dengue therapeutics research and development. J Infect Dis. 2017;215(suppl_2):S96&#x2013;S102. doi: 10.1093/infdis/jiw423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw423</ArticleId><ArticleId IdType="pmc">PMC5388029</ArticleId><ArticleId IdType="pubmed">28403438</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai YC, Chuang YC, Chang CP, Lin YS, Perng GC, Wu HC, Hsieh SL, Yeh TM. Minocycline suppresses dengue virus replication by down-regulation of macrophage migration inhibitory factor-induced autophagy. Antiviral Res. 2018;155:28&#x2013;38. doi: 10.1016/j.antiviral.2018.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.05.002</ArticleId><ArticleId IdType="pubmed">29752950</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017;358(6365):929&#x2013;932. doi: 10.1126/science.aan6836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan6836</ArticleId><ArticleId IdType="pmc">PMC5858873</ArticleId><ArticleId IdType="pubmed">29097492</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson LN, Tharakaraman K, Rowley KJ, Costa VV, Chan KR, Wong YH, Ong LC, Tan HC, Koch T, Cain D, et al. Structure-guided design of an anti-dengue antibody directed to a non-immunodominant epitope. Cell. 2015;162(3):493&#x2013;504. doi: 10.1016/j.cell.2015.06.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.06.057</ArticleId><ArticleId IdType="pmc">PMC4758460</ArticleId><ArticleId IdType="pubmed">26189681</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouvinski A, Guardado-Calvo P, Barba-Spaeth G, Duquerroy S, Vaney MC, Kikuti CM, Navarro Sanchez ME, Dejnirattisai W, Wongwiwat W, Haouz A, et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature. 2015;520(7545):109&#x2013;113. doi: 10.1038/nature14130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14130</ArticleId><ArticleId IdType="pubmed">25581790</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinski A, Jumnainsong A, Edwards C, Quyen NTH, Duangchinda T, et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol. 2015;16(2):170&#x2013;177. doi: 10.1038/ni.3058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3058</ArticleId><ArticleId IdType="pmc">PMC4445969</ArticleId><ArticleId IdType="pubmed">25501631</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M, Zuest R, Velumani S, Tukijan F, Toh YX, Appanna R, Tan EY, Cerny D, MacAry P, Wang CI, et al. A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus. NPJ Vaccines. 2017;2:2. doi: 10.1038/s41541-016-0003-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-016-0003-3</ArticleId><ArticleId IdType="pmc">PMC5627287</ArticleId><ArticleId IdType="pubmed">29263863</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, Lu YT, Huang CH, Lin CF, Anderson R, Liu HS, Yeh TM, Yen YT, Wu-Hsieh BA, Lin YS. Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1. PLoS One. 2014;9(3):e92495. doi: 10.1371/journal.pone.0092495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092495</ArticleId><ArticleId IdType="pmc">PMC3962419</ArticleId><ArticleId IdType="pubmed">24658118</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai YC, Chuang YC, Liu CC, Ho TS, Lin YS, Anderson R, Yeh TM. Antibodies against modified NS1 wing domain peptide protect against dengue virus infection. Sci Rep. 2017;7(1):6975. doi: 10.1038/s41598-017-07308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07308-3</ArticleId><ArticleId IdType="pmc">PMC5539099</ArticleId><ArticleId IdType="pubmed">28765561</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlesinger JJ, Brandriss MW, Walsh EE. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol. 1987;68(Pt 3):853&#x2013;857. doi: 10.1099/0022-1317-68-3-853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-68-3-853</ArticleId><ArticleId IdType="pubmed">3819700</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna VD, Rangappa M, Satchidanandam V. Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells. J Virol. 2009;83(10):4766&#x2013;4777. doi: 10.1128/JVI.01850-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01850-08</ArticleId><ArticleId IdType="pmc">PMC2682061</ArticleId><ArticleId IdType="pubmed">19264772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Wan SW, Chen MC, Lin SC, Cheng CC, Chiu SC, Hsiao YL, Lei HY, Liu HS, Yeh TM, et al. Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model. Lab Invest. 2008;88(10):1079&#x2013;1089. doi: 10.1038/labinvest.2008.70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2008.70</ArticleId><ArticleId IdType="pubmed">18679379</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigne C, Dupuy M, Richetin A, Guy B, Jackson N, Bonaparte M, Hu B, Saville M, Chansinghakul D, Noriega F, et al. Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination. Hum Vaccin Immunother. 2017;13(9):2004&#x2013;2016. doi: 10.1080/21645515.2017.1333211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2017.1333211</ArticleId><ArticleId IdType="pmc">PMC5612045</ArticleId><ArticleId IdType="pubmed">28598256</ArticleId></ArticleIdList></Reference><Reference><Citation>Guy B, Jackson N. Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nat Rev Microbiol. 2016;14(1):45&#x2013;54. doi: 10.1038/nrmicro.2015.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2015.2</ArticleId><ArticleId IdType="pubmed">26639777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadinegoro SR, Arredondo-Garcia JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, et al. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. N Engl J Med. 2015;373(13):1195&#x2013;1206. doi: 10.1056/NEJMoa1506223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1506223</ArticleId><ArticleId IdType="pubmed">26214039</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine. 2017;35(47):6355&#x2013;6358. doi: 10.1016/j.vaccine.2017.09.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.09.089</ArticleId><ArticleId IdType="pubmed">29029938</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Licensed dengue vaccine: Public health conundrum and scientific challenge. Am J Trop Med Hyg. 2016;95(4):741&#x2013;745. doi: 10.4269/ajtmh.16-0222.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.16-0222</ArticleId><ArticleId IdType="pmc">PMC5062765</ArticleId><ArticleId IdType="pubmed">27352870</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, Hauhart RE, Marovich MA, Garred P, Atkinson JP, Diamond MS. Complement-mediated neutralization of dengue virus requires mannose-binding lectin. MBio. 2011;2(6):e00276&#x2013;e00211. doi: 10.1128/mBio.00276-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00276-11</ArticleId><ArticleId IdType="pmc">PMC3236064</ArticleId><ArticleId IdType="pubmed">22167226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YS, Yeh TM, Lin CF, Wan SW, Chuang YC, Hsu TK, Liu HS, Liu CC, Anderson R, Lei HY. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp Biol Med. 2011;236(5):515&#x2013;523. doi: 10.1258/ebm.2011.010339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2011.010339</ArticleId><ArticleId IdType="pubmed">21502191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Wan SW, Cheng HJ, Lei HY, Lin YS. Autoimmune pathogenesis in dengue virus infection. Viral Immunology. 2006;19(2):127&#x2013;132. doi: 10.1089/vim.2006.19.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2006.19.127</ArticleId><ArticleId IdType="pubmed">16817755</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun DS, King CC, Huang HS, Shih YL, Lee CC, Tsai WJ, Yu CC, Chang HH. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost. 2007;5(11):2291&#x2013;2299. doi: 10.1111/j.1538-7836.2007.02754.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02754.x</ArticleId><ArticleId IdType="pubmed">17958746</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MC, Lin CF, Lei HY, Lin SC, Liu HS, Yeh TM, Anderson R, Lin YS. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency. J Immunol. 2009;183(3):1797&#x2013;1803. doi: 10.4049/jimmunol.0800672.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0800672</ArticleId><ArticleId IdType="pubmed">19592650</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu IJ, Chiu CY, Chen YC, Wu HC. Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem. 2011;286(11):9726&#x2013;9736. doi: 10.1074/jbc.M110.170993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.170993</ArticleId><ArticleId IdType="pmc">PMC3058979</ArticleId><ArticleId IdType="pubmed">21233208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YC, Lin YS, Liu HS, Yeh TM. Molecular mimicry between dengue virus and coagulation factors induces antibodies to inhibit thrombin activity and enhance fibrinolysis. J Virol. 2014;88(23):13759&#x2013;13768. doi: 10.1128/JVI.02166-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02166-14</ArticleId><ArticleId IdType="pmc">PMC4248957</ArticleId><ArticleId IdType="pubmed">25231318</ArticleId></ArticleIdList></Reference><Reference><Citation>Henchal EA, Henchal LS, Schlesinger JJ. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J Gen Virol. 1988;69(Pt 8):2101&#x2013;2107. doi: 10.1099/0022-1317-69-8-2101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-69-8-2101</ArticleId><ArticleId IdType="pubmed">3404125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, Chen PW, Chen CY, Lai YC, Chu YT, Hung CY, Lee H, Wu HF, Chuang YC, Lin J, et al. Therapeutic effects of monoclonal antibody against dengue virus NS1 in a STAT1 knockout mouse model of dengue infection. J Immunol. 2017;199(8):2834&#x2013;2844. doi: 10.4049/jimmunol.1601523.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601523</ArticleId><ArticleId IdType="pubmed">28904127</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu YT, Wan SW, Chang YC, Lee CK, Wu-Hsieh BA, Anderson R, Lin YS. Antibodies against nonstructural protein 1 protect mice from dengue virus-induced mast cell activation. Lab Invest. 2017;97(5):602. doi: 10.1038/labinvest.2017.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2017.10</ArticleId><ArticleId IdType="pubmed">28240747</ArticleId></ArticleIdList></Reference><Reference><Citation>Falgout B, Bray M, Schlesinger JJ, Lai CJ. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J Virol. 1990;64(9):4356&#x2013;4363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247903</ArticleId><ArticleId IdType="pubmed">2143542</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava AK, Putnak JR, Warren RL, Hoke CH. Mice immunized with a dengue type-2 virus-E and NS1 fusion protein made in Escherichia-Coli are protected against lethal dengue virus-infection. Vaccine. 1995;13(13):1251&#x2013;1258. doi: 10.1016/0264-410X(94)00059-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0264-410X(94)00059-V</ArticleId><ArticleId IdType="pubmed">8578812</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim JH, Diniz MO, Cariri FAMO, Rodrigues JF, Bizerra RSP, Goncalves AJS, Alves AMD, Ferreira LCD. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine. 2012;30(5):837&#x2013;845. doi: 10.1016/j.vaccine.2011.12.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.12.034</ArticleId><ArticleId IdType="pubmed">22178517</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu SF, Liao CL, Lin YL, Yeh CT, Chen LK, Huang YF, Chou HY, Huang JL, Shaio MF, Sytwu HK. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. Vaccine. 2003;21(25-26):3919&#x2013;3929. doi: 10.1016/S0264-410X(03)00310-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(03)00310-4</ArticleId><ArticleId IdType="pubmed">12922127</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa SM, Freire MS, Alves AMB. DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus. Vaccine. 2006;24(21):4562&#x2013;4564. doi: 10.1016/j.vaccine.2005.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2005.08.022</ArticleId><ArticleId IdType="pubmed">16140430</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves AJ, Oliveira ER, Costa SM, Paes MV, Silva JF, Azevedo AS, Mantuano-Barradas M, Nogueira AC, Almeida CJ, Alves AM. Cooperation between CD4+ T Cells and humoral immunity is critical for protection against dengue using a DNA vaccine based on the NS1 antigen. PLoS Negl Trop Dis. 2015;9(12):e0004277. doi: 10.1371/journal.pntd.0004277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004277</ArticleId><ArticleId IdType="pmc">PMC4674122</ArticleId><ArticleId IdType="pubmed">26650916</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa SM, Azevedo AS, Paes MV, Sarges FS, Freire MS, Alves AMB. DNA vaccines against dengue virus based on the ns1 gene: The influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice. Virology. 2007;358(2):413&#x2013;423. doi: 10.1016/j.virol.2006.08.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.08.052</ArticleId><ArticleId IdType="pubmed">17020777</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>